Dual HDAC/PI3K inhibitors as a potential and emerging cancer therapy: a review.

ifupinostat (BEBT-908) - BeBetter Med

fimepinostat (CUDC-907) - Curis

http://www.ncbi.nlm.nih.gov/pubmed/42420202

Madhukumari; Akshatha Handattu Shankaranarayana; Arun Kumar S; Durgesh Bidye; Gurubasavaraj V Pujar; Salini P Nair

Jul 9, 2026